About Satyadeva Pharmaceuticals Private Limited
Data last updated:
Satyadeva Pharmaceuticals Private Limited is a private limited company based in Medak, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 August 2000 and has been in existence for over 26 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2000PTC035107. Its GSTIN is 36AAFCS6182F1Z7 (Telangana).
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹2 Cr. It is led by directors including Eswara Narayana Kosaraju (Managing Director) and Srinivasa Rao Tubati (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot Nos. 19 To 28 Phase II Ida Pashamylaram, Medak, Telangana, India – 502307.
As per the financials filed for FY 2025, the company reported a revenue of ₹102.95 Cr, a growth of 5% compared to the previous year. For the same year it recorded a net profit of ₹3.1 Cr (net margin 3%) and EBITDA of ₹8.01 Cr (EBITDA margin 7.8%). Revenue has declined at a compounded annual rate (CAGR) of 4% over three years and 19% over five years.
The company has about 149 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Satyadeva Pharmaceuticals. As per MCA filings, the company has open charges of ₹13.09 Cr and satisfied charges of ₹39.65 Cr on record. Court records list 1 case involving the company, including 1 filed by the company.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website satyadevapharma.com.
Company details
CIN history
Satyadeva Pharmaceuticals has one previous CIN (Corporate Identification Number): U24239AP2000PTC035107. The current CIN is U24239TG2000PTC035107, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG2000PTC035107 | Current |
| U24239AP2000PTC035107 | Previous |
Contact details
Satyadeva Pharmaceuticals Private Limited's registered office is in Medak, Telangana. Its website is satyadevapharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot Nos. 19 To 28 Phase II Ida Pashamylaram, Medak, Telangana, India – 502307
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Satyadeva Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Satyadeva Pharmaceuticals operates one associated brand: Satyadeva Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures pharmaceutical intermediates and provides contract manufacturing services globally. | satyadevapharma.com |
Business activity
The main business activity of Satyadeva Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Satyadeva Pharmaceuticals Private Limited, buy the company report.
Financials of Satyadeva Pharmaceuticals Private Limited
FY 2025 filings availableSatyadeva Pharmaceuticals Private Limited reported revenue of ₹102.95 Cr (up 5% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 5% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 19%. EBITDA rose 39% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹8.01 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.1 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.8% | ||||
| Net Profit Margin | 3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Satyadeva Pharmaceuticals Private Limited, buy the company report.
Board of directors of Satyadeva Pharmaceuticals Private Limited
Satyadeva Pharmaceuticals has 5 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Srinivasa Rao Tubati | Whole-Time Director | 21 Jul 2005 | 21 Years 3 Months | Current |
| Venkata Prasad Averineni Also directs: Chemexel Speciality Chemicals Private Limited | Whole-Time Director | 21 Jul 2005 | 21 Years 3 Months | Current |
| Swathi Nandamuri | Director | 01 Apr 2019 | 7 Years 6 Months | Current |
| Eswara Narayana Kosaraju Also directs: Swathi Fine Chem Private Limited | Managing Director | 11 Aug 2000 | 26 Years 2 Months | Current |
| Hari Krishna Kosaraju Also directs: Nandamuri Taraka Rama Rao Arts LLP | Director | 01 Apr 2019 | 7 Years 6 Months | Current |
Peer comparison
Satyadeva Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sirmaxo Chemicals Pvt Ltd | ₹103.62 Cr (FY 2025) | 6.0% | Mumbai, Maharashtra, India | |||
| Makcur Laboratories Limited | ₹103.51 Cr (FY 2025) | 14.0% | Dehgam, Gujarat, India | |||
| Vasista Pharma Chem Private Limited | ₹103.26 Cr (FY 2025) | 22.0% | Atchutapuram, Andhra Pradesh, India | |||
| Satyadeva Pharmaceuticals Private Limitedthis company | ₹102.95 Cr (FY 2025) | ₹3.1 Cr | 3% | 5.0% | 149 | Medak, Telangana, India |
| Aura Lifecare Private Limited | ₹102.72 Cr (FY 2025) | 15.0% | Savli, Gujarat, India | |||
| Baroque Pharmaceuticals Pvt Ltd | ₹102.39 Cr (FY 2025) | 7.0% | Ahmedabad, Gujarat, India | |||
| Makson Industries Private Limited | ₹101.93 Cr (FY 2018) | 4.0% | Mandideep, Madhya Pradesh, India |
To see the full peer comparison of Satyadeva Pharmaceuticals Private Limited, buy the company report.
Auditor
Satyadeva Pharmaceuticals Private Limited is audited by Brahmayya & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Brahmayya & Co. | FY 2023 | 000513S |
Shareholding
The shareholding of Satyadeva Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Satyadeva Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 13 Mar 2025 | 101066338 | Hdfc Bank Limited | ₹99 Lakh | Open | |
| 07 Nov 2024 | 101023543 | Others | ₹5 Cr | Open | |
| 23 Jun 2016 | 100038814 | Axis Bank Limited | ₹7.1 Cr | Open | |
| 30 Oct 2017 | 100149559 | Hdfc Bank Limited | ₹18 Cr | Satisfied | |
| 22 Aug 2016 | 100049270 | Axis Bank Limited | ₹16.6 Cr | Satisfied |
To see the full charge records of Satyadeva Pharmaceuticals Private Limited, buy the company report.
Total charge records: 8 View all charges
Legal cases
Satyadeva Pharmaceuticals Private Limited has 1 court case on record: 1 filed by Satyadeva Pharmaceuticals. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, TELANGANA | Writ petition | Filed by the company against Central Pollution Control Board, and 3 others | Disposed |
To see the full case history of Satyadeva Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Satyadeva Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Satyadeva Pharmaceuticals Private Limited has a workforce of 149 employees on its EPFO records as of Sep 24, 2025, across 1 active EPFO establishment.
GST
Satyadeva Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAFCS6182F1Z7 | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Satyadeva Pharmaceuticals Private Limited, buy the company report.
Recent activity
Satyadeva Pharmaceuticals Private Limited has 9 board changes on record since 2000: 7 appointments and 2 cessations. The latest: Hari Krishna Kosaraju was appointed as Director on 01 Apr 2019.
17 earlier events are in the company report.
Frequently asked questions
Satyadeva Pharmaceuticals is an active private limited company based in Medak, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 August 2000 (26+ years old) and is registered under CIN U24239TG2000PTC035107.
Satyadeva Pharmaceuticals has 5 current directors:
- Eswara Narayana Kosaraju - Managing Director
- Srinivasa Rao Tubati - Whole-Time Director
- Venkata Prasad Averineni - Whole-Time Director
- Swathi Nandamuri - Director
- Hari Krishna Kosaraju - Director
The latest financial statements of Satyadeva Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Satyadeva Pharmaceuticals is 36AAFCS6182F1Z7, registered in Telangana.
The CIN (Corporate Identification Number) of Satyadeva Pharmaceuticals is U24239TG2000PTC035107. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Satyadeva Pharmaceuticals has 1 court case on record: 1 filed by the company.
Satyadeva Pharmaceuticals was incorporated on 11 August 2000, making it 26+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Satyadeva Pharmaceuticals by revenue are Sirmaxo Chemicals Pvt Ltd, Makcur Laboratories Limited, Vasista Pharma Chem Private Limited, Aura Lifecare Private Limited, Baroque Pharmaceuticals Pvt Ltd and 1 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Hari Krishna Kosaraju was appointed as Director on 01 Apr 2019. Swathi Nandamuri was appointed as Director on 01 Apr 2019. Buragadda Srinivasa Rao ceased to be Director on 11 Sep 2012. Satyadeva Pharmaceuticals has 9 board changes on record in total.
Satyadeva Pharmaceuticals can be reached through the website satyadevapharma.com. Its registered office is in Medak, Telangana, India.
The registered office of Satyadeva Pharmaceuticals is at Plot Nos. 19 To 28 Phase II Ida Pashamylaram, Medak, Telangana, India – 502307.